Quantitative Susceptibility Mapping and R2* of Ischemia–Reperfusion Injury Relates to Reactive Oxygen Species Activity
Аннотация
ABSTRACT Purpose Iron deposition following ischemia–reperfusion injury (IRI) plays a catalytic role in reactive oxygen species (ROS) production, contributing to myocardial injury and subsequent heart failure. There is a need for noninvasive imaging methods that quantify iron deposition and ROS activity post‐IRI. We aimed to evaluate the relationship between myocardial iron content, measured by quantitative susceptibility mapping (QSM) and R2*, and ROS activity using PET. Methods IRI was induced in eight swine by percutaneous coronary artery occlusion. Three to seven days post‐infarction, cardiac magnetic resonance imaging was performed to acquire multi‐echo gradient echo images to reconstruct QSM and R2* maps. ROS activity was quantified using a ROS‐activated radiotracer [18F]ROStrace and corrected for myocardial blood flow. Results Magnetic susceptibility and R2* were significantly elevated in hemorrhagic myocardial regions compared to remote myocardium (susceptibility: 0.07 ± 0.08 vs. −0.03 ± 0.05 ppm, p value = 0.02; R2*: 43.9 ± 5.0 vs. 23.6 ± 5.6 Hz, p value = 0.0003). Infarct ROS activity was significantly higher than in remote regions (0.15 ± 0.04 vs. 0.11 ± 0.04 mL/g, p value = 0.0009). A moderate and positive correlation was found across R2*, susceptibility and ROS activity, with the strongest association between R2* and ROS activity (bootstrapped ρ = 0.59, p value = 0.073; uncorrected ρ = 0.65, p value = 0.02). Conclusion This study demonstrates a moderate association between iron‐sensitive MRI biomarkers in the myocardium and ROS activity in IRI. These findings suggest a relationship between iron‐related tissue changes and ROS and highlight R2* and QSM as important imaging biomarkers, potentially aiding in the evaluation of therapeutic targets for treatment of myocardial reperfusion injury.